STAT3 activation plays a role in CTCL pathogenesis (125) and progression (126) and large-cell transformations (127) MiRNAs, such as miR-337 (123) and miR-124 (128), mediate the expression of STAT3. This evidence concerns the gene STAT3 and primary cutaneous T-cell non-Hodgkin lymphoma.